On November 20, 2023, Dyne Therapeutics Inc (NASDAQ: DYN) opened at $11.02, lower -3.36% from the last session. During the day, the shares moved up to $11.45 and dropped to $10.52 before settling in for the closing price of $11.02. Price fluctuations for DYN have ranged from $6.40 to $15.60 over the past 52 weeks.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
Company’s average yearly earnings per share was noted -16.59% at the time writing. With a float of $31.26 million, this company’s outstanding shares have now reached $55.64 million.
The firm has a total of 123 workers. Let’s measure their productivity.
Dyne Therapeutics Inc (DYN) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Dyne Therapeutics Inc is 49.08%, while institutional ownership is 61.37%. The most recent insider transaction that took place on Nov 02, was worth 73,549. In this transaction Chief Operating Officer of this company sold 9,939 shares at a rate of $7.40, taking the stock ownership to the 94,605 shares. Before that another transaction happened on Sep 18, when Company’s insider sold 12,032 for $9.41, making the entire transaction worth $113,221. This insider now owns 233,679 shares in total.
Dyne Therapeutics Inc (DYN) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/29/2023, the company posted -$0.99 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.83) by -$0.16. This company achieved a return on equity of -54.18. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.76 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -16.59% per share during the next fiscal year.
Dyne Therapeutics Inc (NASDAQ: DYN) Trading Performance Indicators
Check out the current performance indicators for Dyne Therapeutics Inc (DYN). In the past quarter, the stock posted a quick ratio of 5.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.59, a number that is poised to hit -0.90 in the next quarter and is forecasted to reach -3.06 in one year’s time.
Technical Analysis of Dyne Therapeutics Inc (DYN)
Analysing the last 5-days average volume posted by the [Dyne Therapeutics Inc, DYN], we can find that recorded value of 0.8 million was better than the volume posted last year of 0.46 million. As of the previous 9 days, the stock’s Stochastic %D was 75.03%. Additionally, its Average True Range was 0.89.
During the past 100 days, Dyne Therapeutics Inc’s (DYN) raw stochastic average was set at 67.68%, which indicates a significant decrease from 82.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 132.46% in the past 14 days, which was higher than the 86.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.58, while its 200-day Moving Average is $11.06. Now, the first resistance to watch is $11.23. This is followed by the second major resistance level at $11.80. The third major resistance level sits at $12.16. If the price goes on to break the first support level at $10.30, it is likely to go to the next support level at $9.94. Now, if the price goes above the second support level, the third support stands at $9.37.
Dyne Therapeutics Inc (NASDAQ: DYN) Key Stats
There are currently 61,376K shares outstanding in the company with a market cap of 653.70 million. Presently, the company’s annual sales total 0 K according to its annual income of -168,100 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -60,210 K.